Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Immunovant
IMVT
$8.11B
| $4.35M | ﹤0.01% |
788,838
-31,561
| -4% | -$197K |
|
2877
Tenaya Therapeutics
TNYA
$170M
| $4.34M | ﹤0.01% |
368,217
+139,078
| +61% | +$1.68M |
|
2878
Cricut
CRCT
$1.27B
| $4.34M | ﹤0.01% |
331,296
+6,374
| +2% | +$110K |
|
2879
NWPX Infrastructure Inc
NWPX
$1.2B
| $4.33M | ﹤0.01% |
170,276
+5,503
| +3% | +$158K |
|
2880
Mirum Pharmaceuticals
MIRM
$6.45B
| $4.33M | ﹤0.01% |
196,438
+23,545
| +14% | +$480K |
|
|
POSH
2881
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $4.31M | ﹤0.01% |
340,460
-13,951
| -4% | -$202K |
|
|
ENFN
2882
DELISTED
Enfusion, Inc.
ENFN
| $4.31M | ﹤0.01% |
338,829
+12,403
| +4% | +$189K |
|
2883
FS Bancorp
FSBW
$323M
| $4.31M | ﹤0.01% |
138,955
+1,434
| +1% | +$46.7K |
|
2884
Orrstown Financial Services
ORRF
$852M
| $4.3M | ﹤0.01% |
187,588
+7,106
| +4% | +$173K |
|
|
FRBK
2885
DELISTED
Republic First Bancorp Inc
FRBK
| $4.29M | ﹤0.01% |
831,631
+43,473
| +6% | +$209K |
|
2886
Phathom Pharmaceuticals
PHAT
$666M
| $4.27M | ﹤0.01% |
313,817
+20,619
| +7% | +$333K |
|
|
BRDG
2887
DELISTED
Bridge Investment Group
BRDG
| $4.26M | ﹤0.01% |
209,627
+32,646
| +18% | +$683K |
|
|
ONTF
2888
DELISTED
ON24
ONTF
| $4.26M | ﹤0.01% |
324,385
+28,915
| +10% | +$435K |
|
2889
Alkami Technology
ALKT
$2.01B
| $4.26M | ﹤0.01% |
297,461
+12,227
| +4% | +$187K |
|
2890
Edgewise Therapeutics
EWTX
$4.84B
| $4.25M | ﹤0.01% |
438,141
+46,559
| +12% | +$599K |
|
|
RUBY
2891
DELISTED
Rubius Therapeutics, Inc
RUBY
| $4.25M | ﹤0.01% |
770,636
+266
| +0% | +$1.69K |
|
2892
Kura Sushi USA
KRUS
$598M
| $4.24M | ﹤0.01% |
76,817
+6,905
| +10% | +$357K |
|
|
CLVS
2893
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.24M | ﹤0.01% |
2,096,698
-115,914
| -5% | -$228K |
|
2894
Humacyte
HUMA
$197M
| $4.23M | ﹤0.01% |
599,789
-4,523
| -0.7% | -$26.3K |
|
|
ADTH
2895
DELISTED
AdTheorent Holding Co
ADTH
| $4.23M | ﹤0.01% |
429,909
+400,048
| +1,340% | +$2.81M |
|
2896
Tower Semiconductor
TSEM
$23.9B
| $4.22M | ﹤0.01% |
87,272
+525
| +0.6% | +$22.2K |
|
2897
Noodles & Co
NDLS
$108M
| $4.21M | ﹤0.01% |
88,267
+4,520
| +5% | +$277K |
|
2898
SoundThinking
SSTI
$102M
| $4.21M | ﹤0.01% |
151,833
+2,613
| +2% | +$71.2K |
|
|
VTNR
2899
DELISTED
Vertex Energy, Inc
VTNR
| $4.2M | ﹤0.01% |
422,162
+26,801
| +7% | +$164K |
|
2900
SandRidge Energy
SD
$487M
| $4.19M | ﹤0.01% |
261,396
-11,963
| -4% | -$154K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,081 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.